Coromandel International Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 7:47 pm

Quick Insight

Coromandel International Ltd, a prominent player in the fertilisers industry, boasts a robust financial profile with a market capitalization of ₹66,510 Cr. The company's price-to-earnings ratio stands at 33.7, indicating a favorable valuation. With a return on equity of 16.8% and return on capital employed at an impressive 23.2%, Coromandel International demonstrates efficient utilization of resources. Notably, the firm maintains a healthy operating profit margin of 11% and a solid interest coverage ratio of 14.10x. Moreover, the company's diverse shareholding pattern, including significant promoter ownership at 56.96%, underscores investor confidence. With a price-to-book value of 3.36x and substantial reserves of ₹11,058 Cr, Coromandel International appears well-positioned for sustainable growth in the fertilisers sector.

Competitors of Coromandel International Ltd

All Competitor Stocks of Coromandel International Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:30 pm

Below is a detailed analysis of the quarterly data for Coromandel International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 7,042.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,988.00 Cr. (Mar 2025) to 7,042.00 Cr., marking an increase of 2,054.00 Cr..
• For Expenses, as of Jun 2025, the value is 6,260.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,579.00 Cr. (Mar 2025) to 6,260.00 Cr., marking an increase of 1,681.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 782.00 Cr.. The value appears strong and on an upward trend. It has increased from 409.00 Cr. (Mar 2025) to 782.00 Cr., marking an increase of 373.00 Cr..
• For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Mar 2025) to 11.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 84.00 Cr.. The value appears to be declining and may need further review. It has decreased from 473.00 Cr. (Mar 2025) to 84.00 Cr., marking a decrease of 389.00 Cr..
• For Interest, as of Jun 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.00 Cr. (Mar 2025) to 68.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 121.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 85.00 Cr. (Mar 2025) to 121.00 Cr., marking an increase of 36.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 677.00 Cr.. The value appears to be declining and may need further review. It has decreased from 731.00 Cr. (Mar 2025) to 677.00 Cr., marking a decrease of 54.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Mar 2025) to 26.00%, marking an increase of 5.00%.
• For Net Profit, as of Jun 2025, the value is 502.00 Cr.. The value appears to be declining and may need further review. It has decreased from 578.00 Cr. (Mar 2025) to 502.00 Cr., marking a decrease of 76.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 17.13. The value appears to be declining and may need further review. It has decreased from 19.67 (Mar 2025) to 17.13, marking a decrease of 2.54.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:58 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 3:23 pm

Below is a detailed analysis of the balance sheet data for Coromandel International Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 29.00 Cr..
• For Reserves, as of Mar 2025, the value is 11,058.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,390.00 Cr. (Mar 2024) to 11,058.00 Cr., marking an increase of 1,668.00 Cr..
• For Borrowings, as of Mar 2025, the value is 780.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 492.00 Cr. (Mar 2024) to 780.00 Cr., marking an increase of 288.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 7,049.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,933.00 Cr. (Mar 2024) to 7,049.00 Cr., marking an increase of 1,116.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 18,917.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15,845.00 Cr. (Mar 2024) to 18,917.00 Cr., marking an increase of 3,072.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 4,139.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,112.00 Cr. (Mar 2024) to 4,139.00 Cr., marking an increase of 1,027.00 Cr..
• For CWIP, as of Mar 2025, the value is 396.00 Cr.. The value appears strong and on an upward trend. It has increased from 235.00 Cr. (Mar 2024) to 396.00 Cr., marking an increase of 161.00 Cr..
• For Investments, as of Mar 2025, the value is 1,031.00 Cr.. The value appears strong and on an upward trend. It has increased from 854.00 Cr. (Mar 2024) to 1,031.00 Cr., marking an increase of 177.00 Cr..
• For Other Assets, as of Mar 2025, the value is 13,351.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,644.00 Cr. (Mar 2024) to 13,351.00 Cr., marking an increase of 1,707.00 Cr..
• For Total Assets, as of Mar 2025, the value is 18,917.00 Cr.. The value appears strong and on an upward trend. It has increased from 15,845.00 Cr. (Mar 2024) to 18,917.00 Cr., marking an increase of 3,072.00 Cr..

Notably, the Reserves (11,058.00 Cr.) exceed the Borrowings (780.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Coromandel International Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 55.81. This value is within the healthy range. It has decreased from 68.51 (Mar 23) to 55.81, marking a decrease of 12.70.
• For Diluted EPS (Rs.), as of Mar 24, the value is 55.81. This value is within the healthy range. It has decreased from 68.38 (Mar 23) to 55.81, marking a decrease of 12.57.
• For Cash EPS (Rs.), as of Mar 24, the value is 64.39. This value is within the healthy range. It has decreased from 75.49 (Mar 23) to 64.39, marking a decrease of 11.10.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 320.88. It has increased from 268.97 (Mar 23) to 320.88, marking an increase of 51.91.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 320.88. It has increased from 268.97 (Mar 23) to 320.88, marking an increase of 51.91.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 749.27. It has decreased from 1,007.75 (Mar 23) to 749.27, marking a decrease of 258.48.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 89.34. This value is within the healthy range. It has decreased from 105.35 (Mar 23) to 89.34, marking a decrease of 16.01.
• For PBIT / Share (Rs.), as of Mar 24, the value is 81.57. This value is within the healthy range. It has decreased from 99.16 (Mar 23) to 81.57, marking a decrease of 17.59.
• For PBT / Share (Rs.), as of Mar 24, the value is 75.24. This value is within the healthy range. It has decreased from 92.70 (Mar 23) to 75.24, marking a decrease of 17.46.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 56.63. This value is within the healthy range. It has decreased from 69.30 (Mar 23) to 56.63, marking a decrease of 12.67.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 55.78. This value is within the healthy range. It has decreased from 68.47 (Mar 23) to 55.78, marking a decrease of 12.69.
• For PBDIT Margin (%), as of Mar 24, the value is 11.92. This value is within the healthy range. It has increased from 10.45 (Mar 23) to 11.92, marking an increase of 1.47.
• For PBIT Margin (%), as of Mar 24, the value is 10.88. This value is within the healthy range. It has increased from 9.83 (Mar 23) to 10.88, marking an increase of 1.05.
• For PBT Margin (%), as of Mar 24, the value is 10.04. This value is within the healthy range. It has increased from 9.19 (Mar 23) to 10.04, marking an increase of 0.85.
• For Net Profit Margin (%), as of Mar 24, the value is 7.55. This value is within the healthy range. It has increased from 6.87 (Mar 23) to 7.55, marking an increase of 0.68.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 7.44. This value is below the healthy minimum of 8. It has increased from 6.79 (Mar 23) to 7.44, marking an increase of 0.65.
• For Return on Networth / Equity (%), as of Mar 24, the value is 17.43. This value is within the healthy range. It has decreased from 25.45 (Mar 23) to 17.43, marking a decrease of 8.02.
• For Return on Capital Employeed (%), as of Mar 24, the value is 24.04. This value is within the healthy range. It has decreased from 34.79 (Mar 23) to 24.04, marking a decrease of 10.75.
• For Return On Assets (%), as of Mar 24, the value is 10.35. This value is within the healthy range. It has decreased from 14.14 (Mar 23) to 10.35, marking a decrease of 3.79.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 0.01, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.47. It has decreased from 2.32 (Mar 23) to 1.47, marking a decrease of 0.85.
• For Current Ratio (X), as of Mar 24, the value is 2.07. This value is within the healthy range. It has increased from 1.75 (Mar 23) to 2.07, marking an increase of 0.32.
• For Quick Ratio (X), as of Mar 24, the value is 1.28. This value is within the healthy range. It has increased from 0.99 (Mar 23) to 1.28, marking an increase of 0.29.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.00. This value is below the healthy minimum of 4. It has decreased from 4.84 (Mar 23) to 3.00, marking a decrease of 1.84.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 10.75. This value is below the healthy minimum of 20. It has decreased from 17.51 (Mar 23) to 10.75, marking a decrease of 6.76.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 9.44. This value is below the healthy minimum of 20. It has decreased from 16.06 (Mar 23) to 9.44, marking a decrease of 6.62.
• For Earning Retention Ratio (%), as of Mar 24, the value is 89.25. This value exceeds the healthy maximum of 70. It has increased from 82.49 (Mar 23) to 89.25, marking an increase of 6.76.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 90.56. This value exceeds the healthy maximum of 70. It has increased from 83.94 (Mar 23) to 90.56, marking an increase of 6.62.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 14.10. This value is within the healthy range. It has decreased from 16.30 (Mar 23) to 14.10, marking a decrease of 2.20.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 9.94. This value is within the healthy range. It has decreased from 11.72 (Mar 23) to 9.94, marking a decrease of 1.78.
• For Enterprise Value (Cr.), as of Mar 24, the value is 28,896.11. It has increased from 24,436.79 (Mar 23) to 28,896.11, marking an increase of 4,459.32.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.31. This value is within the healthy range. It has increased from 0.82 (Mar 23) to 1.31, marking an increase of 0.49.
• For EV / EBITDA (X), as of Mar 24, the value is 10.99. This value is within the healthy range. It has increased from 7.89 (Mar 23) to 10.99, marking an increase of 3.10.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.44. This value is within the healthy range. It has increased from 0.87 (Mar 23) to 1.44, marking an increase of 0.57.
• For Retention Ratios (%), as of Mar 24, the value is 89.24. This value exceeds the healthy maximum of 70. It has increased from 82.48 (Mar 23) to 89.24, marking an increase of 6.76.
• For Price / BV (X), as of Mar 24, the value is 3.36. This value exceeds the healthy maximum of 3. It has increased from 3.27 (Mar 23) to 3.36, marking an increase of 0.09.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.44. This value is within the healthy range. It has increased from 0.87 (Mar 23) to 1.44, marking an increase of 0.57.
• For EarningsYield, as of Mar 24, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.05, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness